Close

Jefferies Sees Nearly 100% Upside in Synta Pharma. (SNTA)

June 25, 2012 8:02 AM EDT Send to a Friend
Jefferies doubled its price target on Synta Pharma. (NASDAQ: SNTA) from $7 to $14 ahead of GALAXY Interim Data.

This article: 135 words
-->

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login